Robert Mashal, Director at Nuvation Bio Inc. (NUVB), bought 100,000 shares at $1.67 ($167K) on 2025-04-01, disclosed to the SEC on 2025-04-03.
Open-market purchase of $167k NUVB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.67 | 1,100 | $2K | 1.1% |
| 2 | $1.67 | 98,900 | $165K | 98.9% |
| Total | $1.67 avg | 100,000 | $167K | 100% |
| Filing → |